Compare Adhi Karya Persero Tbk (ADHI) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adhi Karya Persero Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Adhi Karya Persero Tbk trades at Rp143 (market cap 1.2T, 4.2M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,760 (market cap 12.54T, 60.3K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 10.4× Adhi Karya Persero Tbk's market cap, and Adhi Karya Persero Tbk is more actively traded (4.2M versus 60.3K). Which is the better fit depends on your goals.
| ADHI | TSPC | |
|---|---|---|
Market Cap | 1.2T | 12.54T |
Volume | 4.2M | 60.3K |
Lot | 41.98K | 603 |
Turnover | 594.55M | 166.57M |
Average Price | 141.62 | 2,762.37 |
Value | 594.55M | 166.57M |
Indicative Equilibrium Price | 143 | 2,780 |
Indicative Equilibrium Volume | 23.2K | 500 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adhi Karya Persero Tbk
The name of Adhi karya for the first time was stated in Decree of the Minister of Public Works and Labor on March 11, 1960. Subsequently, based on Government Regulation No. 65 of 1961, Adhi Karya was determined as a State Owned Company Adhi Karya. In the same year, based on the same Government Regulation, a former Dutch-owned construction company that has been nationalized, Associate NV, was merged into the Company. PT Adhi Karya (Persero) Tbk was established on Jun 1, 1974.
Read more on ADHI →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
